Aflibercept Biosimilars Market – Expanding Competition in Biologic Eye Care
The Aflibercept Biosimilars Market concerns biosimilar versions of aflibercept, a biologic medicine used in certain retinal and ophthalmic conditions. Aflibercept works by inhibiting vascular endothelial growth factor (VEGF) activity, which can help manage abnormal blood vessel growth and fluid leakage in the eye in approved indications.
Current Market Landscape
Aflibercept is used in...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek